EUVIMEDEUVIMED entdecken
Open Access · CC BY-NC 3.0

Precision Targeting of Human M2 Macrophages by Magnetic Nanoparticles Functionalized with an in-House Antibody

Chloe Bazile, Julie Bordenave, Saber Amri iD, Flavien Raynal, Laetitia Ligat, Manon Farcé, Henri Coste, Pascal Clerc, Olivier Sandre, Corinne Bousquet, Vera Pancaldi iD, Stéphane Mornet und 2 weitere

International Journal of Nanomedicine · 2026

DOI: 10.2147/ijn.s619574 ↗

Kurz gefasst

Fachartikel in der Zeitschrift International Journal of Nanomedicine, 2026. Verfasst von Chloe Bazile und 13 weiteren Autor:innen. Beteiligte Einrichtung: Inserm, CNRS, Toulouse III-Paul Sabatier University, Cancer Research Center of Toulouse, Toulouse, France. Hauptthemen laut MEDLINE: Antibodies, Monoclonal, Magnetite Nanoparticles, Carcinoma, Non-Small-Cell Lung, Macrophages. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 3.0).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Introduction

Non-small cell lung cancer (NSCLC) remains the leading cause of cancer-related mortality, particularly due to resistance induced by tumor-associated macrophages (TAMs)-exhibiting a M2-like phenotype-within the tumor microenvironment. The specific targeting of pro-tumoral M2 TAMs constitutes thus a major challenge in anticancer therapies but current strategies lack specificity. We produced and patented a monoclonal antibody, called mAb6-25, that specifically targets M2-like macrophages (M2M) but not M1-like macrophages (M1M) or monocytes. Here, we investigated the conjugation of this antibody on magnetic nanoparticles (MNPs) as a potential nanoplatform for specific M2 TAM targeting.

Methods

Magnetic iron oxide multicore nanoflowers (NF) were functionalized with a fluorophore allowing their detection and the mAb6-25 for M2 TAM targeting. The M2M targeting by MNP-mAb6-25 was determined, comparatively to M1M, in 2D and 3D in vitro co-culture models with cancer cells by flow cytometry and confocal microscopy analysis, while MNP-mAb6-25 uptake was evaluated by NMR relaxometry. The in vivo M2 TAM targeting was analyzed in a xenograft mouse model of NSCLC by IVIS optical imaging.

Results

We demonstrated that the MNP-mAb6-25 nanoplatform preferentially binds M2M compared to M1M (13-fold higher uptake in M2M) or cancer cells in monoculture as well as in 2D and 3D co-culture models mixing M2M or M1M with A549 NSCLC cells. Moreover, MNP-mAb6-25 internalized and accumulated in the lysosomes of M2M. The efficacy of intravenously injected MNP-mAb6-25 to target NSCLC sub-cutaneous xenografted models containing M2M was subsequently demonstrated.

Conclusion

This study highlights the potential of MNP-mAb6-25 as a nanoplatform for selective targeting TAM-containing NSCLC tumors. This nanotechnology tool may lead to the development of new applications: one involving the imaging-based detection of pro-tumoral M2 TAMs by MRI, and the other involving their potential depletion through the application of localized magnetic fields, paving the way for imaging-guided diagnosis and further therapeutic evaluation.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Antibodies, MonoclonalMagnetite NanoparticlesCarcinoma, Non-Small-Cell LungMacrophagesTumor-Associated MacrophagesHumansAnimalsLung NeoplasmsMiceCell Line, TumorFemale

Stichwörter der Autor:innen

antibodyimagingmacrophagemagnetic fieldmagnetic nanoparticlestargeting

Substanzen

Antibodies, MonoclonalMagnetite Nanoparticles

Autor:innen und Institutionen

  • Inserm, CNRS, Toulouse III-Paul Sabatier University, Cancer Research Center of Toulouse, Toulouse, France.
  • CNRS, Bordeaux INP, ICMCB, Bordeaux University, UMR 5026, Pessac, France.
  • CNRS, Bordeaux INP, LCPO, Bordeaux University, UMR 5629, Pessac, France.

ORCID-Profile: Saber Amri, Vera Pancaldi, Mary Poupot

Zitieren

APA

Bazile, C., Bordenave, J., Amri, S., Raynal, F., Ligat, L., Farcé, M., Coste, H., Clerc, P., Sandre, O., Bousquet, C., Pancaldi, V., Mornet, S., Gigoux, V., & Poupot, M. (2026). Precision Targeting of Human M2 Macrophages by Magnetic Nanoparticles Functionalized with an in-House Antibody. International Journal of Nanomedicine. https://doi.org/10.2147/ijn.s619574

Vancouver

Bazile C, Bordenave J, Amri S, Raynal F, Ligat L, Farcé M, et al. Precision Targeting of Human M2 Macrophages by Magnetic Nanoparticles Functionalized with an in-House Antibody. International Journal of Nanomedicine. 2026. doi:10.2147/ijn.s619574

BibTeX
@article{Bazile2026,
  author = {Bazile, Chloe and Bordenave, Julie and Amri, Saber and Raynal, Flavien and Ligat, Laetitia and Farcé, Manon and Coste, Henri and Clerc, Pascal and Sandre, Olivier and Bousquet, Corinne and Pancaldi, Vera and Mornet, Stéphane and Gigoux, Veronique and Poupot, Mary},
  title = {Precision Targeting of Human M2 Macrophages by Magnetic Nanoparticles Functionalized with an in-House Antibody},
  journal = {International Journal of Nanomedicine},
  year = {2026},
  doi = {10.2147/ijn.s619574}
}
Kostenlos starten →